Daily Archives: February 24, 2022
RCT: In comatose survivors of cardiac arrest, a strategy of suppressing rhythmic and periodic EEG activity with the use of antiseizure medication did not improve neurologic outcomes.
24 Feb, 2022 | 10:45h | UTCTreating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
In trial of comatose patients after cardiac arrest, intensive antiseizure treatment adapted from protocols for status epilepticus did not result in fewer poor outcomes at 3 mos than standard treatment. https://t.co/dpH5cgwhvW pic.twitter.com/zVBHBYMRK9
— NEJM (@NEJM) February 23, 2022
Editorial: Addressing vaccine inequity — Covid-19 vaccines as a global public good.
24 Feb, 2022 | 10:41h | UTC
Previous population immunity and Covid-19 severity with Omicron variant in South Africa.
24 Feb, 2022 | 10:43h | UTCAudio Interview: Understanding the Omicron Variant of SARS-CoV-2
Commentary on Twitter
In Gauteng, South Africa, where the omicron variant was first identified, two thirds of unvaccinated residents were seropositive for SARS-CoV-2, which indicates past infection. Omicron peaked just 1 month after being detected. #COVID19 https://t.co/Z8qTI1DNkv pic.twitter.com/ZZv2xevacG
— NEJM (@NEJM) February 23, 2022
RCT: Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine.
24 Feb, 2022 | 10:20h | UTCCommentary: Suspend Methotrexate for RA Patients Getting COVID Vax?— It’s not a simple choice, Brazilian study suggests (free registration required)
[Preprint] Fourth dose of COVID vaccine offers only slight boost against Omicron infection.
24 Feb, 2022 | 10:30h | UTCFourth dose of COVID vaccine offers only slight boost against Omicron infection – Nature
Original Study: 4th Dose COVID mRNA Vaccines’ Immunogenicity & Efficacy Against Omicron VOC – medRxiv
Two large populational-based studies find a slightly increased risk of thrombotic events following AstraZeneca COVID-19 vaccination.
24 Feb, 2022 | 10:23h | UTCCommentaries:
Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax – TCTMD
Mortality from congenital Zika Syndrome — nationwide cohort study in Brazil.
24 Feb, 2022 | 10:18h | UTC
Point-of-care testing and home testing: pragmatic considerations for widespread incorporation: stool tests, serum tests, intestinal ultrasound.
24 Feb, 2022 | 10:04h | UTC
Ramadan fasting: recommendations for patients with cardiovascular disease.
24 Feb, 2022 | 10:17h | UTCRamadan fasting: recommendations for patients with cardiovascular disease – Heart
Related:
WHO Interim Guidance: Safe Ramadan Practices in the Context of the COVID-19
Position Statement: Guidance for People with Types 1 and 2 Diabetes Who Fast During Ramadan
Diabetes and Ramadan: Practical guidelines
Commentary on Twitter
Ramadan fasting: recommendations for patients with cardiovascular diseasehttps://t.co/genOJm0Vu4 pic.twitter.com/9E3awbPcvB
— Heart_BMJ (@Heart_BMJ) July 26, 2021
Current State of Imaging of Pediatric Pancreatitis: AJR Expert Panel Narrative Review.
24 Feb, 2022 | 10:13h | UTC
Clinical practice guideline: exercise and lifestyle in chronic kidney disease.
24 Feb, 2022 | 10:15h | UTCClinical practice guideline exercise and lifestyle in chronic kidney disease – BMC Nephrology
ASCO Report: Use of Biosimilar Medications in Oncology.
24 Feb, 2022 | 10:08h | UTCUse of Biosimilar Medications in Oncology – JCO Oncology Practice
News Release: New ASCO Report Clarifies Potential Value and Utility of Biosimilars in Oncology – ASCO Daily News
SMFM Guidance: Use of analgesia and anesthesia for maternal-fetal procedures.
24 Feb, 2022 | 10:10h | UTC
Review: Enhanced recovery after surgery for major orthopedic surgery.
24 Feb, 2022 | 10:01h | UTCSee also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review.
24 Feb, 2022 | 10:11h | UTC
M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.
24 Feb, 2022 | 10:02h | UTCSecondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentary: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (free registration required)
Related:
RCT: Cytoreductive surgery for relapsed ovarian cancer.
Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies.
24 Feb, 2022 | 10:05h | UTC
A review of mucinous cystic and intraductal neoplasms of the pancreatobiliary tract: recent advances.
24 Feb, 2022 | 09:59h | UTC